Os 10-03 the Distinctive Effect of Polysaccharide Peptides Ganoderma Lucidum as Anti Atherogenesis in Stable Angina Patients

Ubaidillah, Nizamuddin; Sargowo, Djanggan; Widya, Adriyawan; Jakfar,; Ks, Proboretno; Failasufi, Mirza; Warahugraha, Y; Ramadhan, Fadhli; Wulandari, Hesti; Dh, Putri

doi:10.1097/01.hjh.0000500039.08261.4f

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study examining 37 patients with high risk for atherosclerosis and on an ongoing conventional CVD medication, G. lucidum PsP was able to reduce the levels hs-CRP, IL-6, and TNF-a, as well as the levels of MDA (Widya et al, 2016). Another study involving 34 stable angina pectoris patients showed that administration of PsP in combination with previous medication is able to significantly reduce CECs and EPCs (markers for endothelial vascular injury) as well as the levels of total cholesterol (Ubaidillah et al, 2016).…”

Section: In Vivo Preclinical Evaluation Of G Lucidummentioning

confidence: 99%

Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety

et al. 2020

View full text Add to dashboard Cite

Cardiovascular diseases (CVDs) are a significant health burden with an ever-increasing prevalence. They remain the leading causes of morbidity and mortality worldwide. The use of medicinal herbs continues to be an alternative treatment approach for several diseases including CVDs. Currently, there is an unprecedented drive for the use of herbal preparations in modern medicinal systems. This drive is powered by several aspects, prime among which are their cost-effective therapeutic promise compared to standard modern therapies and the general belief that they are safe. Nonetheless, the claimed safety of herbal preparations yet remains to be properly tested. Consequently, public awareness should be raised regarding medicinal herbs safety, toxicity, potentially lifethreatening adverse effects, and possible herb-drug interactions. Over the years, laboratory data have shown that medicinal herbs may have therapeutic value in CVDs as they can interfere with several CVD risk factors. Accordingly, there have been many attempts to move studies on medicinal herbs from the bench to the bedside, in order to effectively employ herbs in CVD treatments. In this review, we introduce CVDs and their risk factors. Then we overview the use of herbs for disease treatment in general and CVDs in particular. Further, data on the ethnopharmacological therapeutic potentials and medicinal properties against CVDs of four widely used plants, namely Ginseng, Ginkgo biloba, Ganoderma lucidum, and Gynostemma pentaphyllum, are gathered and reviewed. In particular, the employment of these four plants in the context of CVDs, such as myocardial infarction, hypertension, peripheral vascular diseases, coronary heart disease, cardiomyopathies, and dyslipidemias has been reviewed, analyzed, and critically discussed. We also endeavor to document the recent studies aimed to dissect the cellular and molecular cardio-protective mechanisms of the four plants, using recently reported in vitro and in vivo studies. Finally, we reviewed and reported the results of the

show abstract

Section: In Vivo Preclinical Evaluation Of G Lucidummentioning

confidence: 99%